Codexis CEO Resigns

Codexis CEO Alan Shaw resigned from his long-standing position at the enzyme developer to “pursue other interests,” sending stock prices 16% lower, to $3.81/share. Shaw has been with Codexis since its founding and was named CEO in 2002. He also led the enzyme maker through its 2010 initial public offering. Former senior v.p. and head of pharmaceuticals Peter Strumph will serve as interim CEO. Shaw’s departure closely follows news that CFO Bob Lawson will leave the company in following the company’s annual report filing. Market sources...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers